Intelligence · Clinical Development
Pipeline search results
Programs matching “etoposide” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 12 pipeline programs matching "etoposide" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
CWS-2007-HR
Solid Biosciences
Soft Tissue Sarcoma
1 trial -
ETOPOSIDE
Pari Pharma GmbH
Hemophagocytic lymphohistiocytosis (HLH)
1 trial -
ETOPOSIDE , DEXAMETHASONE
Pari Pharma GmbH
Hemophagocytic lymphohistiocytosis (HLH)
1 trial -
ETOPOSIDE - Usual
Lxo Ireland Designated Activity Company
Small Cell Lung Cancer
1 trial -
Etoposide
The First People's Hospital of Lianyungang
Multiple Myeloma
1 trial -
Etoposide
The First People's Hospital of Lianyungang
Non-Hodgkin's Lymphoma
1 trial -
Obatoclax Mesylate, Carboplatine and Etoposide
Teva Pharma GmbH
Extensive-stage Small Cell Lung Cancer
1 trial -
2023-SR-002
The First People's Hospital of Lianyungang
NK-T-Cell Lymphoma, Extranodal
1 trial -
Etoposide
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Multiple Myeloma
1 trial -
Etoposide
The First People's Hospital of Lianyungang
Small Cell Lung Cancer Limited Stage
1 trial -
Karelizumab combined with etoposide and cisplatin
Jian Li
Carcinoma
1 trial -
Etoposide
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Mantle Cell Lymphoma
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.